The mere idea that some future vaccine might end up "working" to get things back to "normal" was enough to drive up Moderna's stock prices by a whopping 30 percent. Whether or not an actual vaccine that truly works ever comes to fruition is beside the point: If investors are able to rake in some cash on that bet, then this is all that really matters.
Just nine hours after news about the vaccine made headlines, Moderna was out there looking to raise $1 billion in new capital for its commercial development. And off went Moncef Slaoui, one of the company's former board members, straight to the White House to get the job done.
Money is the driver in all of this, in other words, not necessarily the quest for a "cure." As long as Moderna can convince investors that things are on the up-and-up moving forward, then the money will keep on flowing as the markets react as intended.
Keep in mind that Moderna never actually released any follow-up data on the claims made about its "miracle" vaccine. For all we know, it was just a bunch of empty promises designed to jack up the price of the company's stock offering, which is what many are now speculating.
Earlier in the year, it is important to note, Moderna's stock had taken a few tumbles and was in a volatile position. But ever since the vaccine announcement, things have shifted in the other direction.
In the end, none of this will really matter because the likelihood of the U.S. dollar imploding in the very near future is a certain 100 percent. Listen below to The Health Ranger Report to learn more:
These latest developments with Moderna really serve as a case study in how the stock market is nothing but a game for unscrupulous investors, who in all reality are really just gamblers betting in the casino known as Wall Street.
With the Wuhan coronavirus (COVID-19) really putting a damper on the Wall Street gambling hall in recent months, Moderna's announcement about an up-and-coming vaccine that would fix everything really gave the markets that shock injection they needed to produce the positive numbers that all stakeholders, including the president, have been demanding.
However, you can be sure that the system is barely on life support at this point, the prospect of a novel remedy for the novel virus that the world is now having to grapple with being the only hopeful thing keeping the financial markets intact, at least from a distance.
By maintaining the illusion of stability and a hopeful future, investors and other stakeholders will continue to play the table, so to speak, keeping the wheels turning. But eventually the music stops, and then what? Will a vaccine really end up being the thing that keeps the American financial system afloat? Hardly.
In many ways, Americans are watching the deck chairs being rearranged on the Titanic. More than likely, there is no going back to the "old normal," and much worse is still to come, including for the financial markets. How long it will all take to come into view is still a guessing game, but do not be fooled: "tremendous," "incredible," and the various other adjectives our president often uses to describe the current state of things are hardly accurate.
More of the latest news about the Wuhan coronavirus (COVID-19) is available at Pandemic.news.
Sources for this article include: